Homology Medicinesincis A Genetic Medicines Company Based In Bedfordmassachusettsdedicated To Improving The Lives Of Patients With Rare Genetic Diseasesfounded In 2015The Company Specializes In Gene Editing And Gene Therapy Technologies Aimed At Repairing Or Replacing Genes Responsible For Genetic Disorders The Company Utilizes Its Aavhscadeno Associated Virus Human Stem Cellplatform To Deliver Functional Genes For Treating Monogenic Diseases Across Various Tissuesincluding The Liver And Lungshomology Medicines Has A Strong Product Pipeline That Includes Gene Therapies For Conditions Such As Phenylketonuriametachromatic Leukodystrophyand Hunter Syndromeas Well As Investigational Gene Editing Programs With A Focus On Collaborationhomology Medicines Engages With Stakeholders In The Healthcare Industryincluding Pharmaceutical Companies And Research Institutionsthe Company Has Raised Over $127 Million And Holds A Portfolio Of Patents Related To Molecular Biology And Rare Diseasessupporting Its Innovative Approaches To Treatment
